Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012 ; volume:12 ; number:1 ; day:16 ; month:2 ; year:2017 ; pages:1-7 ; date:12.2017
Orphanet journal of rare diseases ; 12, Heft 1 (16.2.2017), 1-7, 12.2017
- Keyword
-
Arzneimittelentwicklung
Arzneimitteldesign
- Creator
-
Pauwels, Kim
- Contributor
-
Huys, Isabelle
Casteels, Minne
Larsson, Kristina
Voltz, Caroline
Penttila, Karri
Morel, Thomas
Simoens, Steven
SpringerLink (Online service)
- DOI
-
10.1186/s13023-017-0578-4
- URN
-
urn:nbn:de:1111-2017031012819
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pauwels, Kim
- Huys, Isabelle
- Casteels, Minne
- Larsson, Kristina
- Voltz, Caroline
- Penttila, Karri
- Morel, Thomas
- Simoens, Steven
- SpringerLink (Online service)
Other Objects (12)
Clinical evidence for orphan medicinal products-a cause for concern?
Comparing access to orphan medicinal products in Europe
The European challenges of funding orphan medicinal products
Establishment of a value assessment framework for orphan medicinal products in China
10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Off-label use of orphan medicinal products: a Belgian qualitative study
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
Geographic Indications as flagship products for sustainable landscape management in the European Union
The Orphan
Orphan Island
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
Indications
Clinical evidence for orphan medicinal products-a cause for concern?
Comparing access to orphan medicinal products in Europe
The European challenges of funding orphan medicinal products
Establishment of a value assessment framework for orphan medicinal products in China
10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Off-label use of orphan medicinal products: a Belgian qualitative study
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
Geographic Indications as flagship products for sustainable landscape management in the European Union
The Orphan
Orphan Island
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
Indications
Clinical evidence for orphan medicinal products-a cause for concern?
Comparing access to orphan medicinal products in Europe
The European challenges of funding orphan medicinal products
Establishment of a value assessment framework for orphan medicinal products in China
10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Off-label use of orphan medicinal products: a Belgian qualitative study
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
Geographic Indications as flagship products for sustainable landscape management in the European Union
The Orphan
Orphan Island
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study